First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy for Age-Related Macular Degeneration.
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
- Status
- UNKNOWN
- Phase
- PHASE3
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE3
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2